Bison Wealth’s Traws Pharma TRAW Stock Holding History

Bison Wealth’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-28	Closed	-$10K	–	499
2021 Q1	$10K	Buy	+28	New	+$10.6K	﹤0.01%	421

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Bison Wealth's TRAW Position: Q2 2021 in Review

Bison Wealth sold out of Traws Pharma (TRAW) in Q2 2021, closing a stake of 28 shares — an estimated $10K sold.

Bison Wealth first reported a position in TRAW in Q1 2021 and held it in 1 quarter. The position peaked at $10K in Q1 2021. 25 funds tracked by Wall St. Rank hold TRAW as of Q2 2021.

Bison Wealth reported no remaining Traws Pharma position as of Q2 2021 after selling out during the quarter.
Bison Wealth sold 28 Traws Pharma shares in Q2 2021, an estimated $10K.
Bison Wealth first reported a position in Traws Pharma in Q1 2021 and held it in 1 quarter.
Bison Wealth's Traws Pharma position peaked at $10K in Q1 2021.
25 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2021.

Based on Bison Wealth's 13F filing for Q2 2021, filed 2 Aug 2021.